Literature DB >> 24818851

Prostate cancer: surgery versus observation for localized prostate cancer.

Roderick C N van den Bergh1, Gianluca Giannarini2.   

Abstract

A key study comparing radical prostatectomy and watchful waiting for prostate cancer has been updated with extended follow-up observation, demonstrating substantial benefits of surgery for reduced mortality mainly in younger men, but also reduced requirement for palliative treatment in older men. These findings should be interpreted within the current scenario of prostate cancer diagnosis and treatment.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24818851     DOI： 10.1038/nrurol.2014.109

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


  10 in total

1.  Radical prostatectomy versus observation for localized prostate cancer.

Authors:  Timothy J Wilt; Michael K Brawer; Karen M Jones; Michael J Barry; William J Aronson; Steven Fox; Jeffrey R Gingrich; John T Wei; Patricia Gilhooly; B Mayer Grob; Imad Nsouli; Padmini Iyer; Ruben Cartagena; Glenn Snider; Claus Roehrborn; Roohollah Sharifi; William Blank; Parikshit Pandya; Gerald L Andriole; Daniel Culkin; Thomas Wheeler
Journal:  N Engl J Med       Date:  2012-07-19       Impact factor: 91.245

2.  Abiraterone and increased survival in metastatic prostate cancer.

Authors:  Johann S de Bono; Christopher J Logothetis; Arturo Molina; Karim Fizazi; Scott North; Luis Chu; Kim N Chi; Robert J Jones; Oscar B Goodman; Fred Saad; John N Staffurth; Paul Mainwaring; Stephen Harland; Thomas W Flaig; Thomas E Hutson; Tina Cheng; Helen Patterson; John D Hainsworth; Charles J Ryan; Cora N Sternberg; Susan L Ellard; Aude Fléchon; Mansoor Saleh; Mark Scholz; Eleni Efstathiou; Andrea Zivi; Diletta Bianchini; Yohann Loriot; Nicole Chieffo; Thian Kheoh; Christopher M Haqq; Howard I Scher
Journal:  N Engl J Med       Date:  2011-05-26       Impact factor: 91.245

Review 3.  Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.

Authors:  Osamu Ukimura; Jonathan A Coleman; Alex de la Taille; Mark Emberton; Jonathan I Epstein; Stephen J Freedland; Gianluca Giannarini; Adam S Kibel; Rodolfo Montironi; Guillaume Ploussard; Monique J Roobol; Vincenzo Scattoni; J Stephen Jones
Journal:  Eur Urol       Date:  2012-09-25       Impact factor: 20.096

4.  Prostate cancer and the Will Rogers phenomenon.

Authors:  Peter C Albertsen; James A Hanley; George H Barrows; David F Penson; Pam D H Kowalczyk; M Melinda Sanders; Judith Fine
Journal:  J Natl Cancer Inst       Date:  2005-09-07       Impact factor: 13.506

5.  Prostate-cancer mortality at 11 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

6.  Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial.

Authors:  Andrew Vickers; Caroline Bennette; Gunnar Steineck; Hans-Olov Adami; Jan-Erik Johansson; Anna Bill-Axelson; Juni Palmgren; Hans Garmo; Lars Holmberg
Journal:  Eur Urol       Date:  2012-04-19       Impact factor: 20.096

7.  Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.

Authors:  Eva Johansson; Anna Bill-Axelson; Lars Holmberg; Erik Onelöv; Jan-Erik Johansson; Gunnar Steineck
Journal:  Eur Urol       Date:  2008-09-02       Impact factor: 20.096

8.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Authors:  Gerrit Draisma; Rob Boer; Suzie J Otto; Ingrid W van der Cruijsen; Ronald A M Damhuis; Fritz H Schröder; Harry J de Koning
Journal:  J Natl Cancer Inst       Date:  2003-06-18       Impact factor: 13.506

9.  Radical prostatectomy or watchful waiting in early prostate cancer.

Authors:  Anna Bill-Axelson; Lars Holmberg; Hans Garmo; Jennifer R Rider; Kimmo Taari; Christer Busch; Stig Nordling; Michael Häggman; Swen-Olof Andersson; Anders Spångberg; Ove Andrén; Juni Palmgren; Gunnar Steineck; Hans-Olov Adami; Jan-Erik Johansson
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

10.  Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.

Authors:  Firas Abdollah; Maxine Sun; Jan Schmitges; Rodolphe Thuret; Marco Bianchi; Shahrokh F Shariat; Alberto Briganti; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Journal:  J Urol       Date:  2012-05-12       Impact factor: 7.450
  10 in total
  3 in total

1.  Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality.

Authors:  Kathryn L Pellegrini; Martin G Sanda; Dattatraya Patil; Qi Long; María Santiago-Jiménez; Mandeep Takhar; Nicholas Erho; Kasra Yousefi; Elai Davicioni; Eric A Klein; Robert B Jenkins; R Jeffrey Karnes; Carlos S Moreno
Journal:  BJU Int       Date:  2017-02-11       Impact factor: 5.588

2.  PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience.

Authors:  Roberta Merola; Luigi Tomao; Anna Antenucci; Isabella Sperduti; Steno Sentinelli; Serena Masi; Chiara Mandoj; Giulia Orlandi; Rocco Papalia; Salvatore Guaglianone; Manuela Costantini; Giuseppe Cusumano; Giovanni Cigliana; Paolo Ascenzi; Michele Gallucci; Laura Conti
Journal:  J Exp Clin Cancer Res       Date:  2015-02-06

3.  Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.

Authors:  Dehua Zhang; Muchun Zhang; Qifu Zhang; Zhiyi Zhao; Yong Nie
Journal:  Med Sci Monit       Date:  2020-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.